Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Surgery|October 1, 2013
EZH2-shRNA-mediated upregulation of p21waf1/cip1 and its transcriptional enhancers with concomitant downmodulation of mutant p53 in pancreatic ductal adenocarcinomaRamesh B Batchu, Aamer M Qazi, Oksana V Gruzdyn, et al.Annals of Surgical Oncology|August 6, 2003
Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcomeLisa A Newman, Nat L Pernick, Volkan Adsay, et al.Journal of Vascular Surgery|January 7, 2003
Outcome of catheter-directed thrombolysis for lower extremity arterial bypass occlusionMark R Nehler, Renee J Mueller, Robert B McLafferty, et al.Surgery|September 5, 2012
Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101Aamer M Qazi, Oksana Gruzdyn, Assaad Semaan, et al.Journal of Vascular Surgery|January 18, 2008
The hemodynamics and diagnosis of venous diseaseMark H Meissner, Gregory Moneta, Kevin Burnand, et al.Pharmaceutical Research|August 6, 2011
MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf¹/cip¹)Assaad Semaan, Aamer M Qazi, Shelly Seward, et al.Journal of Surgical Education|October 11, 2020
Impact of Surgery Program Characteristics on Fate of Non-designated Preliminary Surgery InternsKaitlin A Ritter, Rahul J Anand, Kathleen Beard, et al.Cancer Letters|April 23, 2013
EZH2 blockade by RNA interference inhibits growth of ovarian cancer by facilitating re-expression of p21(waf1/cip1) and by inhibiting mutant p53Shelly Seward, Assaad Semaan, Aamer M Qazi, et al.The Journal of Surgical Research|July 3, 2022
A Multicenter Analysis of the Early Impact of COVID-19 on Junior Resident Operative Case VolumeBenjamin Kramer, Gilman Plitt, Judith C French, et al.Pageof 5